  | Sautois, B., Loehr, A., Watkins, S. P., SCHROEDER, H., & Abida, W. (2022). A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a RAD51B Alteration. Current Oncology, 29 (6), 4178-4184. doi:10.3390/curroncol29060333  Peer Reviewed verified by ORBi |
 | ONESTI, C. E., Schroeder, H., Rorive, A., Sautois, B., Lecocq, M., Goffin, M., Gonne, E., Collinge, A., Nicolaers, L., Wéra, O., Catot, A., Loly, C., Paulus, A., Sibille, A., Lousberg, L., Troisfontaine, F., Collignon, J., Gennigens, C., Frères, P., ... Jerusalem, G. (2021). Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study. Cancer Reports, 1571. doi:10.1002/cnr2.1571 Peer reviewed |
  | ONESTI, C. E., SCHROEDER, H., RORIVE, A., SAUTOIS, B., LECOCQ, M., Goffin, M., GONNE, E., COLLINGE, A., NICOLAERS, L., WERA, O., Catot, A., LOLY, C., PAULUS, A., SIBILLE, A., LOUSBERG, L., Troisfontaine, F., COLLIGNON, J., GENNIGENS, C., FRERES, P., & JERUSALEM, G. (2020). How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain. |
 | LECOCQ, M., ONESTI, C. E., SCHROEDER, H., RORIVE, A., Goffin, M., GONNE, E., SAUTOIS, B., Catot, A., WERA, O., NICOLAERS, L., COLLINGE, A., Collignon, J., FRERES, P., POLUS, M., DUYSINX, B., VAILLANT, F., GENNIGENS, C., MARCHAL, N., PONCIN, A., & JERUSALEM, G. (2020). Risk of SARS-CoV-2 infection and outcome after infection : Experience from the day-care unit at CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain. |
 | Wenric, S., El Guendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., Olivier, F., Jossa, V., JERUSALEM, G., JOSSE, C., & BOURS, V. (May 2017). Transcriptome wide analysis of natural antisense transcripts shows potential role in breast cancer [Poster presentation]. 50th meeting of the European Society of Human Genetics, Copenhagen, Denmark. |
 | Wenric, S., ElGuendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., OLIVIER, F., Jossa, V., Jerusalem, G., JOSSE, C., & Bours, V. (2017). Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Scientific Reports, 7 (1), 17452. doi:10.1038/s41598-017-17811-2 Peer Reviewed verified by ORBi |
 | BRAGARD, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., LIFRANGE, E., SCHROEDER, H., Wagener, A., Dupuis, G., & Jerusalem, G. (2017). A non-randomized comparison study of self-hypnosis, yoga and cognitive behavioral therapy to reduce emotional distress in breast cancer patients. International Journal of Clinical and Experimental Hypnosis, 65 (2), 189-209. doi:10.1080/00207144.2017.1276363 Peer Reviewed verified by ORBi |
 | Yip, C., Foidart, P., Somja, J., Truong, A., Lienard, M., Feyereisen, E., SCHROEDER, H., GOFFLOT, S., Donneau, A.-F., COLLIGNON, J., Delvenne, P., Sounni, N. E., Jerusalem, G., & Noël, A. (2017). MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. British Journal of Cancer. doi:10.1038/bjc.2017.23 Peer Reviewed verified by ORBi |
 | SAUTOIS, B., SCHROEDER, H., MARTIN, M., PIRET, P., DEMEZ, P., BOUCHAIN, O., MUTIJIMA NZARAMBA, E., & MOREAU, P. (2016). Weekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma. Journal of Balkan Union of Oncology, 21 (4), 979-988. Peer Reviewed verified by ORBi |
 | Bragard, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., DEVOS, M., LIFRANGE, E., SCHROEDER, H., Wagener, A., & Jerusalem, G. (2016). Etude pilote auprès de patientes atteintes d'un cancer du sein: Apport des méthodes alternatives. In A.-M. Etienne & I. Bragard, Evolutions Sociales, Innovations et Politiques: nouvelles questions et nouveaux enjeux pour la psychologie de la santé (pp. 51-54). Lyon, France: Editions des Archives Contemporaines. Peer reviewed |
 | COLLIGNON, J., LOUSBERG, L., SCHROEDER, H., & JERUSALEM, G. (2016). Triple-negative breast cancer : treatment challenges and solutions. Breast Cancer, 8, 93-107. doi:10.2147/BCTT.S69488 Peer Reviewed verified by ORBi |
 | Bourcy, M., Suarez-Carmona, M., Lambert, J., Francart, M.-E., SCHROEDER, H., Delierneux, C., Skrypek, N., Thompson, E. W., JERUSALEM, G., Berx, G., Thiry, M., Blacher, S., Hollier, B. G., Noël, A., Oury, C., Polette, M., & Gilles, C. (2016). Tissue factor induced by epithelial-mesenchymal transition triggers a pro-coagulant state that drives metastasis of circulating tumor cells. Cancer Research, 76 (14), 4270-4282. Peer Reviewed verified by ORBi |
Bourcy, M., Suarez-Carmona, M., Lambert, J., Francart, M.-E., SCHROEDER, H., Delierneux, C., Thompson, E., Jerusalem, G., Blacher, S., Noël, A., Oury, C., Polette, M., & Gilles, C. (January 2016). Epithelial-mesenchymal transition induces tissue factor and pro-coagulant properties supporting early metastasis of circulating tumor cells [Poster presentation]. GIGA-Day 2016, Belgium. |
 | Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276. Peer reviewed |
 | COLIN, P.-E., SCHROEDER, H., GONNE, E., Hanocq, F., ANDRE, C., RORIVE, A., Jerusalem, G., & COLLIGNON, J. (2015). BIOPSIE DES LESIONS SUSPECTES CHEZ LES PATIENTS AYANT PRESENTE UN CANCER DU SEIN. Revue Médicale de Liège, 70 (11), 563-8. Peer reviewed |
 | SCHROEDER, H., Hanocq, F., COLLIGNON, J., Colin, P.-E., Depuis, Z., Triffaux, F., RORIVE, A., & JERUSALEM, G. (2015). Cancer du sein: intérêt du bilan d’extension par imagerie lors du diagnostic initial et du suivi les trois premières années après le diagnostic. Revue Médicale de Liège, 70 (3), 140-147. Peer reviewed |
Bragard, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., DEVOS, M., LIFRANGE, E., SCHROEDER, H., Wagener, A., Coudert, S., & Jerusalem, G. (16 December 2014). Améliorer le bien-être des patientes atteintes d’un cancer du sein par l’auto-hypnose, le yoga ou la TCC en groupe : faisabilité et premiers résultats au CHU de Liège [Paper presentation]. 8e congrès de l’Association Francophone de Psychologie de la Santé (AFPSA). |
 | Bragard, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., DEVOS, M., LIFRANGE, E., SCHROEDER, H., Wagener, A., & Jerusalem, G. (2014). Self-hypnosis, yoga or CBT group to face breast cancer: feasibility study and first results in Belgium. Psycho-oncology, 23 (suppl 3), 174. Peer Reviewed verified by ORBi |
 | Nizet, Y., Gillet, L., SCHROEDER, H., Lecuivre, C., Louahed, J., Renauld, J. C., Gianello, P., & Vanderplasschen, A. (2011). Antibody production by injection of living cells expressing non self antigens as cell surface type II transmembrane fusion protein. Journal of Immunological Methods. doi:10.1016/j.jim.2011.02.007 Peer Reviewed verified by ORBi |
 | SCHROEDER, H., SKELLY, P., ZIPFEL, P., Losson, B., & Vanderplasschen, A. (January 2009). Subversion of complement by hematophagous parasites. Developmental and Comparative Immunology, 33 (1), 5-13. doi:10.1016/j.dci.2008.07.010 Peer Reviewed verified by ORBi |
 | Gillet, L., Schroeder, H., Mast, J., Thirion, M., Renauld, J. C., Dewals, B. G., & Vanderplasschen, A. (2009). Anchoring tick salivary anticomplement proteins IRAC I and IRAC II to membrane increases their immunogenicity. Veterinary Research, 40, 51. doi:10.1051/vetres/2009034 Peer Reviewed verified by ORBi |
Schroeder, H. (2008). Fundamental and applied studies of Ixodes ricinus salivary proteins [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315078 |
 | Daix, V., Schroeder, H., Praet, N., Georgin, J.-P., Chiappino, I., Gillet, L., de Fays, K., Decrem, Y., Leboulle, G., Godfroid, E., Bollen, A., Pastoret, P.-P., Gern, L., Sharp, P. M., & Vanderplasschen, A. (2007). Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anticomplement proteins. Insect Molecular Biology, 16 (2), 155-66. doi:10.1111/j.1365-2583.2006.00710.x Peer Reviewed verified by ORBi |
 | Schroeder, H., Daix, V., Gillet, L., Renauld, J.-C., & Vanderplasschen, A. (2007). The paralogous salivary anti-complement proteins IRAC I and IRAC II encoded by Ixodes ricinus ticks have broad and complementary inhibitory activities against the complement of different host species. Microbes and Infection, 9 (2), 247-50. doi:10.1016/j.micinf.2006.10.020 Peer Reviewed verified by ORBi |